Product nameAnti-Wnt8a antibody
See all Wnt8a primary antibodies
DescriptionRabbit polyclonal to Wnt8a
Tested applicationsSuitable for: IHC-P, WBmore details
Species reactivityReacts with: Human
Predicted to work with: Cow
Recombinant fragment within Human Wnt8a (internal sequence). The exact sequence is proprietary.
Database link: Q9H1J5
- WB: Human Wnt8a-transfected HEK-293T whole cell lysate. IHC-P: Human colon carcinoma tissue.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.00
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: PBS, 20% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab227611 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/100 - 1/1000.|
|WB||1/1000 - 1/10000. Predicted molecular weight: 39 kDa.|
FunctionLigand for members of the frizzled family of seven transmembrane receptors. May play an important role in the development and differentiation of certain forebrain structures, notably the hippocampus.
Sequence similaritiesBelongs to the Wnt family.
Cellular localizationSecreted > extracellular space > extracellular matrix.
- Information by UniProt
- Protein Wnt-8a antibody
- Protein Wnt-8d antibody
- wingless type MMTV integration site family, member 8A antibody
All lanes : Anti-Wnt8a antibody (ab227611) at 1/5000 dilution
Lane 1 : HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate
Lane 2 : Human Wnt8a-transfected HEK-293T whole cell lysate
Lysates/proteins at 30 µg per lane.
Developed using the ECL technique.
Predicted band size: 39 kDa
Paraffin-embedded human colon carcinoma tissue stained for Wnt8a with ab227611 at 1/250 dilution in immunohistochemical analysis.
ab227611 has not yet been referenced specifically in any publications.